Baker Bros. Advisors LP
84 holdingsFiling period: 2026-06-30Current AUM: $20.33Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | INCY | Incyte Corporation | 30.76M | $3.49B | $3.49B | 17.14% | +17.9K | 2026-06-30 |
| 2 | ONC | BeOne Medicines Ltd. | 8.80M | $2.51B | $3.26B | 16.05% | +2.5K | 2026-06-30 |
| 3 | RVMD | Revolution Medicines, Inc. | 11.44M | $2.14B | $2.10B | 10.35% | +1.89M | 2026-06-30 |
| 4 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.14M | $1.15B | $938.1M | 4.61% | +1.4K | 2026-06-30 |
| 5 | ACAD | ACADIA Pharmaceuticals Inc. | 42.91M | $1.09B | $847.1M | 4.17% | +16.2K | 2026-06-30 |
| 6 | KYMR | Kymera Therapeutics, Inc. | 8.66M | $992.7M | $994.2M | 4.89% | -- | 2026-06-30 |
| 7 | INSM | Insmed Incorporated | 8.80M | $937.8M | $820.9M | 4.04% | +1.38M | 2026-06-30 |
| 8 | CELC | Celcuity Inc. | 7.92M | $828.1M | $520.9M | 2.56% | -- | 2026-06-30 |
| 9 | KOD | Kodiak Sciences Inc. | 19.92M | $776.1M | $1.78B | 8.78% | -- | 2026-06-30 |
| 10 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.60M | $622.3M | $501.4M | 2.47% | -- | 2026-06-30 |
| 11 | PRAX | Praxis Precision Medicines, Inc. | 1.75M | $587.0M | $468.8M | 2.31% | -- | 2026-06-30 |
| 12 | — | Alkermes plc | 10.01M | $524.6M | $524.6M | 2.58% | -- | 2026-06-30 |
| 13 | SMMT | Summit Therapeutics Inc. | 32.79M | $477.7M | $475.4M | 2.34% | -3,604,715 | 2026-06-30 |
| 14 | GRAL | GRAIL, Inc. | 4.03M | $275.0M | $563.6M | 2.77% | -- | 2026-06-30 |
| 15 | ABCL | AbCellera Biologics Inc. | 33.01M | $259.1M | $398.8M | 1.96% | +2.74M | 2026-06-30 |
| 16 | IMVT | Immunovant, Inc. | 5.44M | $209.4M | $153.1M | 0.75% | -22,661 | 2026-06-30 |
| 17 | IDYA | IDEAYA Biosciences, Inc. | 5.01M | $186.7M | $164.7M | 0.81% | +1.06M | 2026-06-30 |
| 18 | — | Kiniksa Pharmaceuticals International, plc | 2.83M | $181.3M | $181.3M | 0.89% | +8.4K | 2026-06-30 |
| 19 | — | Roivant Sciences Ltd. | 4.72M | $166.9M | $166.9M | 0.82% | -150,892 | 2026-06-30 |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.99M | $162.4M | $117.5M | 0.58% | -- | 2026-06-30 |
| 21 | IONS | Ionis Pharmaceuticals, Inc. | 2.05M | $162.4M | $88.9M | 0.44% | -- | 2026-06-30 |
| 22 | EWTX | Edgewise Therapeutics, Inc. | 3.70M | $150.4M | $145.0M | 0.71% | -2,874,221 | 2026-06-30 |
| 23 | REPL | Replimune Group, Inc. | 11.05M | $122.3M | $137.7M | 0.68% | -- | 2026-06-30 |
| 24 | NRIX | Nurix Therapeutics, Inc. | 4.66M | $113.0M | $119.0M | 0.59% | -- | 2026-06-30 |
| 25 | STOK | Stoke Therapeutics, Inc. | 3.34M | $109.2M | $85.0M | 0.42% | -- | 2026-06-30 |
← Scroll →
Page 1 of 4